Hyderabad, Dec. 27 (PTI): Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced...

New Delhi, Dec. 23 (PTI): Bharat Biotech’s intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged...

Hyderabad, Jan. 18 (IANS): Bharat Biotech has urged healthcare workers to ensure that only Covaxin is administered to individuals in the 15-18 years age group....

New Delhi, Jan. 12 (PTI): Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on...

United Nations/Geneva, Sep. 30 (PTI): A decision on Bharat Biotech’s submission seeking emergency use listing (EUL) for its Covaxin Covid-19 vaccine will be made in...

Hyderabad, June 15 (PTI): The supply price of Bharat Biotech’s Covid-19 vaccine Covaxin to the Central government at INR 150 per dose is not sustainable...

New Delhi, May 13 (PTI): India’s apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech’s Covaxin Covid-19 vaccine...

New Delhi, April 25 (PTI): Bharat Biotech has written to the India’s drug regulator seeking extension of the shelf-life of its indigenously developed Covid-19 vaccine...

New Delhi, March 3 (PTI): Bharat Biotech on Wednesday said its Covid-19 vaccine Covaxin has demonstrated an interim vaccine efficacy of 81 per cent in Phase...

New Delhi, Mar. 1 (IANS): Chinese and Russian-linked hacking campaigns in recent weeks targeted Indian vaccine makers Serum Institute of India (SII) and Bharat Biotech, cyber...